Your session is about to expire
← Back to Search
Ultrasound Neuromodulation
Ultrasound Neuromodulation for Essential Tremor (UNMET Trial)
N/A
Recruiting
Led By Leo Sugrue, MD, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients with medically refractory tremor scheduled to undergo MR-guided high-intensity focused ultrasound (HIFU) thalamotomy to treat their tremor at UCSF.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 20-30 min mri scan at the end of the 3-4 hour experimental session
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to study if low-intensity focused ultrasound (LIFU) can temporarily change brain activity and behavior when directed at specific parts of the brain. They will focus on areas associated with essential
Who is the study for?
This trial is for individuals with essential tremor, a condition causing involuntary shaking. Participants should be able to give informed consent and have no other neurological disorders or serious medical conditions that could interfere with the study.
What is being tested?
The study tests low-intensity focused ultrasound (LIFU) on parts of the brain linked to essential tremor. The goal is to see if LIFU can temporarily change brain activity and reduce tremors.
What are the potential side effects?
Potential side effects may include discomfort at the site of ultrasound application, headache, or temporary changes in sensation or mood due to brain stimulation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am scheduled for a special ultrasound treatment at UCSF to manage my severe tremor.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 20-30 min mri scan at the end of the 3-4 hour experimental session
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~20-30 min mri scan at the end of the 3-4 hour experimental session
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Reduction in tremor tremor
Secondary study objectives
Changes in functional connectivity of brain networks
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: To determine the most effective stimulation parameters for DRTT LIFU neuromodulation.Experimental Treatment2 Interventions
Investigators will record wrist accelerometer signals while participants maintain standardized postures that maximally elicit their tremor before, during, and after delivering LIFU stimulation.
Find a Location
Who is running the clinical trial?
University of California, San FranciscoLead Sponsor
2,588 Previous Clinical Trials
14,900,859 Total Patients Enrolled
Focused Ultrasound FoundationOTHER
17 Previous Clinical Trials
400 Total Patients Enrolled
1 Trials studying Essential Tremor
30 Patients Enrolled for Essential Tremor
Leo Sugrue, MD, PhDPrincipal InvestigatorUniversity of California, San Francisco
Share this study with friends
Copy Link
Messenger